Published in Mov Disord on November 15, 2008
Hemimasticatory spasm: report of a case and review of the literature†. Tremor Other Hyperkinet Mov (N Y) (2014) 0.75
Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol (2005) 5.19
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain (2010) 4.77
Benign tremulous parkinsonism. Arch Neurol (2006) 3.92
A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet (2007) 3.28
Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol (2012) 2.95
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol (2008) 2.46
Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm. Neurology (2004) 2.42
When does Parkinson disease start? Arch Neurol (2010) 2.41
Risk factors for dementia with Lewy bodies: a case-control study. Neurology (2013) 2.38
Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol (2002) 2.17
Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc (2009) 2.06
Use of tracheal tube as a splint to prevent intraoperative kinking of gas sampling line. J Neurosurg Anesthesiol (2015) 1.98
Normal pressure hydrocephalus: how often does the diagnosis hold water? Neurology (2011) 1.88
Risk tables for parkinsonism and Parkinson's disease. J Clin Epidemiol (2002) 1.86
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord (2005) 1.81
Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology (2004) 1.77
Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol (2008) 1.72
Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol (2003) 1.63
Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic. J Neurosurg (2003) 1.53
"Myelodysplasia," myeloneuropathy, and copper deficiency. Mayo Clin Proc (2005) 1.52
Myelopathy due to copper deficiency. Neurology (2003) 1.51
Clinical feature profile of spinocerebellar ataxia type 1-8 predicts genetically defined subtypes. Mov Disord (2005) 1.49
Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. Arch Neurol (2009) 1.48
Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc (2006) 1.46
Painful legs and moving toes syndrome: a 76-patient case series. Arch Neurol (2012) 1.46
Rapidly progressive neurodegenerative dementias. Arch Neurol (2009) 1.46
Hematological manifestations of copper deficiency: a retrospective review. Eur J Haematol (2008) 1.43
Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord (2009) 1.43
External reinforcement for extraoral kinking of tracheal tube during pediatric anesthesia. Paediatr Anaesth (2014) 1.38
Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology (2002) 1.36
Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol (2012) 1.34
Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol (2013) 1.32
Imaging features of copper deficiency myelopathy: a study of 25 cases. Neuroradiology (2005) 1.32
Early-onset familial parkinsonism due to POLG mutations. Ann Neurol (2006) 1.31
Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry (2012) 1.29
Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. Arch Neurol (2009) 1.29
Acquired hypocupremia after gastric surgery. Clin Gastroenterol Hepatol (2004) 1.24
Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord (2010) 1.22
Orthostatic myoclonus: a contributor to gait decline in selected elderly. Neurology (2007) 1.22
The spectrum of disorders presenting as adult-onset focal lower extremity dystonia. Parkinsonism Relat Disord (2008) 1.22
Familial aggregation of Parkinson's disease: The Mayo Clinic family study. Ann Neurol (2004) 1.21
Chemical exposures and Parkinson's disease: a population-based case-control study. Mov Disord (2006) 1.20
Role of polyanhydrides as localized drug carriers. J Control Release (2005) 1.17
Localizing parts of faces using a consensus of exemplars. IEEE Trans Pattern Anal Mach Intell (2013) 1.17
Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study. Ann Neurol (2006) 1.16
Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease. Mov Disord (2008) 1.14
Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway. PLoS One (2008) 1.13
Genetic and molecular basis of grain size and grain number and its relevance to grain productivity in higher plants. Genome (2006) 1.11
Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol (2013) 1.11
Autoimmune chorea in adults. Neurology (2013) 1.11
Copper deficiency myelopathy. Arch Neurol (2004) 1.10
Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study. Mov Disord (2005) 1.09
The Mayo Clinic family study of Parkinson's disease: study design, instruments, and sample characteristics. Neuroepidemiology (2005) 1.08
Dopaminergic treatment and nonmotor features of Parkinson disease: the horse lives. Neurology (2013) 1.08
Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol. Parkinsonism Relat Disord (2011) 1.07
Neuroimaging and clinical features in type II (late-onset) Alexander disease. Neurology (2013) 1.07
Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. Arch Neurol (2007) 1.05
Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies? Neurobiol Aging (2009) 1.04
Pharmacovigilance: Boon for the safety and efficacy of Ayuvedic formulations. J Ayurveda Integr Med (2010) 1.04
Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. Arch Neurol (2009) 1.03
Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. Arch Gen Psychiatry (2007) 1.02
Biomarkers of susceptibility to type 1 diabetes with special reference to the Indian population. Indian J Med Res (2007) 1.02
Levodopa-dyskinesia incidence by age of Parkinson's disease onset. Mov Disord (2005) 1.02
Interaction of alpha-synuclein and tau genotypes in Parkinson's disease. Ann Neurol (2005) 1.01
The alien limb phenomenon. J Neurol (2013) 1.01
Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease. Mov Disord (2007) 1.00
Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. Arch Neurol (2005) 1.00
Antiphospholipid antibody-associated chorea. J Rheumatol (2008) 0.99
Gene networks in hexaploid wheat: interacting quantitative trait loci for grain protein content. Funct Integr Genomics (2005) 0.99
Dose comparison of tranexamic acid in pediatric cardiac surgery. Asian Cardiovasc Thorac Ann (2004) 0.99
Prevalence of vitamin D deficiency in apparently healthy children in north India. J Pediatr Endocrinol Metab (2014) 0.98
High school football and risk of neurodegeneration: a community-based study. Mayo Clin Proc (2012) 0.98
Primary diffuse leptomeningeal gliomatosis. Eur Neurol (2009) 0.97
Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics. Inflamm Bowel Dis (2013) 0.97
Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations. Neuromuscul Disord (2008) 0.97
Copper deficiency in celiac disease. J Clin Gastroenterol (2009) 0.97
Bacillus subtilis SepF binds to the C-terminus of FtsZ. PLoS One (2012) 0.96
Chorea as a manifestation of spontaneous CSF leak. Neurology (2006) 0.96
Parkinsonism and dropped head: dystonia, myopathy or both? Parkinsonism Relat Disord (2011) 0.95
Exploiting EPR in polymer drug conjugate delivery for tumor targeting. Curr Pharm Des (2006) 0.95
Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosis. PLoS One (2012) 0.94
Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy. Arch Neurol (2006) 0.94
Cutaneous metastasis in prostatic carcinoma. Indian J Dermatol Venereol Leprol (2009) 0.94
Cognitive decline and hypersomnolence: thalamic manifestations of a tentorial dural arteriovenous fistula (dAVF). Neurocrit Care (2012) 0.94
Risk factors for Parkinson's disease may differ in men and women: an exploratory study. Horm Behav (2012) 0.94
Catatonic disorder due to a general medical or psychiatric condition. J Neuropsychiatry Clin Neurosci (2012) 0.93
Multiple system atrophy: prognostic indicators of survival. Mov Disord (2014) 0.93
Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990. Arch Neurol (2006) 0.93
MRI correlates of alien leg-like phenomenon in corticobasal degeneration. Mov Disord (2005) 0.92
Deep brain stimulation in benign tremulous parkinsonism. Arch Neurol (2011) 0.92
Whole-body tremulousness: isolated generalized polymyoclonus. Arch Neurol (2007) 0.91
Anti-free radical activities of kaempferol isolated from Acacia nilotica (L.) Willd. Ex. Del. Toxicol In Vitro (2008) 0.90
Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer. Mol Pharm (2012) 0.90
Myelopathy due to copper deficiency following gastrointestinal surgery. Arch Neurol (2003) 0.90
Biodegradable injectable in situ depot-forming drug delivery systems. Macromol Biosci (2006) 0.90
Virus-induced gene silencing (VIGS) of genes expressed in root, leaf, and meiotic tissues of wheat. Funct Integr Genomics (2011) 0.88